Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page’s documentation without changing the primary study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new publication citation about the final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma has been added to the Publications section. The document revision has been updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check42 days agoChange DetectedPlatform revision updated from v3.6.0 to v3.6.2, representing an underlying system update that does not affect the displayed study information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study page now indicates that recruitment is closed and no longer seeking participants. This reflects the current participation status in the study overview.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page's revision tag has been updated from v3.5.4 to v3.5.5. This indicates a new build or update to the page's underlying system.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page's revision tag was updated to v3.5.4, indicating a small metadata update. This does not modify the study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.